The Europe medical affairs outsourcing market size was valued at USD 217.1 million in 2019 and expanding at a CAGR of 9.5% over forecast period 2020 to 2027.
The market growth can be attributed to the increase in the number of clinical trials and orphan therapies as well as a rise in the prevalence of rare diseases in Europe.
In addition, pharmaceutical and medical devices companies are outsourcing these services to Contract Research Organizations (CROs) to limit the liability exposure by working with a well-trained outsource company, lower operational costs, reduce regulatory compliance risk, and minimize process delays. Medical affairs service providers have grown significantly in the region owing to rising R&D expenditure and increasing focus of pharmaceutical companies on containing cost.
Biopharmaceutical companies are now ready to outsource their medical affairs activities to achieve better quality and cost. This trend is expected to continue in the future due to the increase in capabilities of CROs to manage each medical affairs function, which would reduce the need for additional efforts of biopharmaceutical companies. Collaborations of pharmaceutical, biopharmaceutical, and medical device companies with CROs are also expected to have a positive impact on the market.
The medical affairs department separates commercial and R&D functions to reduce commercial influence on R&D due to increased scrutiny of the promotion of a therapeutic product by regulatory agencies. It acts as a liaison between the two functions, facilitating the transition of drugs from R&D to commercial. Such stringent regulations are expected to drive the outsourcing of medical affairs activities to more efficient third-parties.
Market Study
Some prominent players in the market include:
Syneos Health Inc.
Ashfield Healthcare Communications
ZEINCRO Group
Wuxi Clinical Development, Inc.
SGS SA
ICON plc
IQVIA Holdings Inc.
The Medical Affairs Company (TMAC)
Indegene
PPD Inc.
Market Segmentation
Services Outlook
Medical Writing & Publishing
Medical Monitoring
Medical Science Liaisons (MSLs)
Medical Information
Others
Industry Outlook
Pharmaceutical
Biopharmaceutical
Medical Devices
Therapeutic Medical Devices
Diagnostic Medical Devices
Country Outlook
Europe
The U.K.
Germany
France
Italy
Spain
Table of Contents
Chapter 1 Methodology And Scope
1.1 Market Segmentation & Scope
1.1.1 Services
1.1.2 Industry
1.1.3 Country Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 DATA ANALYSIS MODELS
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 OBJECTIVE - 1:
1.10.2 OBJECTIVE - 2:
1.10.3 OBJECTIVE - 3:
1.10.4 OBJECTIVE - 4:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Europe Medical Affairs Outsourcing Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing number of clinical trials
3.3.1.2 Cost-effectiveness and high quality services offered by CROs
3.3.1.3 Stringent regulatory scenario
3.3.2 Market Restraint Analysis
3.3.2.1 Inability to hire experienced technical staff
3.3.3 Industry Challenges
3.3.3.1 Managing relationships
3.4 Europe Medical Affairs Outsourcing Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 PESTEL Analysis
3.4.3 Major Deals & Strategic Alliances Analysis
3.4.3.1 Mergers and acquisitions
3.4.3.2 Collaboration
3.4.3.3 Launch
Chapter 4 Europe Medical Affairs Outsourcing Market: Services Segment Analysis
4.1 Europe Medical Affairs Outsourcings: Market Share Analysis, 2019 & 2027
4.2 Medical Writing & Publishing
4.2.1 Medical writing & publishing market, 2016 - 2027 (USD Million)
4.3 Medical Monitoring
4.3.1 Medical monitoring market, 2016 - 2027 (USD Million)
4.4 Medical Science Liaisons (MSLs)
4.4.1 Medical science liaisons (MSLs) market, 2016 - 2027 (USD Million)
4.5 Medical Information
4.5.1 Medical information market, 2016 - 2027 (USD Million)
4.6 Others
4.6.1 Others market, 2016 - 2027 (USD Million)
Chapter 5 Europe Medical Affairs Outsourcing Market: End-use Segment Analysis
5.1 Europe Medical Affairs Outsourcings: Market Share Analysis, 2019 & 2027
5.2 Pharmaceutical
5.2.1 Pharmaceutical market, 2016 - 2027 (USD Million)
5.3 Biopharmaceutical
5.3.1 Biopharmaceutical market, 2016 - 2027 (USD Million)
5.4 Medical Devices
5.4.1 Medical devices market, 2016 - 2027 (USD Million)
5.4.2 Therapeutic Medical Devices
5.4.2.1 Therapeutic medical devices market, 2016 - 2027 (USD Million)
5.4.3 Diagnostic Medical Devices
5.4.3.1 Diagnostic medical devices market, 2016 - 2027 (USD Million)
Chapter 6 Europe Medical Affairs Outsourcing Market: Country Analysis
6.1 Europe Medical Affairs Outsourcing: Market Share Analysis, 2019 & 2027
6.2 Europe
6.2.1 Europe medical affairs outsourcing market, 2016 - 2027 (USD Million)
6.2.2 U.K.
6.2.2.1 U.K. medical affairs outsourcing market, 2016 - 2027 (USD Million)
6.2.3 Germany
6.2.3.1 Germany medical affairs outsourcing market, 2016 - 2027 (USD Million)
6.2.4 France
6.2.4.1 France medical affairs outsourcing market, 2016 - 2027 (USD Million)
6.2.5 Italy
6.2.5.1 Italy medical affairs outsourcing market, 2016 - 2027 (USD Million)
6.2.6 Spain
6.2.6.1 Spain medical affairs outsourcing market, 2016 - 2027 (USD Million)
Chapter 7 Company Profiles
7.1 Company Profiles
7.2 THE MEDICAL AFFAIRS COMPANY
7.2.1 Company overview
7.2.2 Service benchmarking
7.2.3 Strategic initiatives
7.3 Ashfield Healthcare
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Service benchmarking
7.3.4 Strategic initiatives
7.4 ZEINCRO Group
7.4.1 Company overview 67
7.4.2 Service benchmarking
7.5 Indegene
7.5.1 Company overview 69
7.5.2 Service benchmarking
7.6 ICON plc
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Service benchmarking
7.7 IQVIA
7.7.1 Company overview 72
7.7.2 Financial performance
7.7.3 Service benchmarking
7.7.4 Strategic initiatives
7.8 Syneos Health
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Service benchmarking
7.8.4 Strategic initiatives
7.9 PPD Inc
7.9.1 Company overview
7.9.2 Service benchmarking
7.10 Wuxi AppTec
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Service benchmarking
7.11 SGS SA
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Service benchmarking